[HTML][HTML] A dynamic COVID-19 immune signature includes associations with poor prognosis

…, M Fish, L Monin, M Muñoz-Ruiz, DR McKenzie… - Nature medicine, 2020 - nature.com
Improved understanding and management of COVID-19, a potentially life-threatening disease,
could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end…

[HTML][HTML] Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective …

…, AG Laing, M Muñoz-Ruiz, DR McKenzie… - The Lancet …, 2021 - thelancet.com
Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…

[HTML][HTML] IL-17-producing γδ T cells switch migratory patterns between resting and activated states

DR McKenzie, EE Kara, CR Bastow, TS Tyllis… - Nature …, 2017 - nature.com
Interleukin 17-producing γδ T (γδT17) cells have unconventional trafficking characteristics,
residing in mucocutaneous tissues but also homing into inflamed tissues via circulation. …

[HTML][HTML] Normality sensing licenses local T cells for innate-like tissue surveillance

DR McKenzie, R Hart, N Bah, DS Ushakov… - Nature …, 2022 - nature.com
The increasing implication of lymphocytes in general physiology and immune surveillance
outside of infection poses the question of how their antigen receptors might be involved. Here, …

[PDF][PDF] Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer

DR McKenzie, M Muñoz-Ruiz, L Monin, T Alaguthurai… - Cancer Cell, 2021 - cell.com
Patients with cancer are considered to be at high-risk for SARS-CoV-2 infection and severe
COVID-19 (Bakouny et al., 2020). Our ‘‘SOAP-02’’(Sars-CoV-2 fOr cAncer Patients) study …

[HTML][HTML] Tailored immune responses: novel effector helper T cell subsets in protective immunity

…, CR Bastow, CE Gregor, DR McKenzie… - PLoS …, 2014 - journals.plos.org
Differentiation of naïve CD4 + cells into functionally distinct effector helper T cell subsets,
characterised by distinct “cytokine signatures,” is a cardinal strategy employed by the …

[HTML][HTML] CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells

EE Kara, DR McKenzie, CR Bastow, CE Gregor… - Nature …, 2015 - nature.com
IL-17-producing helper T (Th17) cells are critical for host defense against extracellular
pathogens but also drive numerous autoimmune diseases. Th17 cells that differ in their …

[HTML][HTML] The emerging complexity of γδT17 cells

DR McKenzie, I Comerford, B Silva-Santos… - Frontiers in …, 2018 - frontiersin.org
Preprogrammed IL-17-producing γδ T cells constitute a poorly understood class of lymphocytes
that express rearranged antigen receptors but appear to make little use of them. γδT17 …

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority …

…, AG Laing, M Muñoz-Ruiz, DR McKenzie… - MedRxiv, 2021 - medrxiv.org
Background The efficacy and safety profile of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) have not been definitively established in …

A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis

…, A Das, M Fish, L Monin, M Munoz-Ruiz, DR McKenzie… - MedRxiv, 2020 - medrxiv.org
Person-to-person transmission of SARS-CoV-2 virus has triggered a global emergency
because of its potential to cause life-threatening Covid-19 disease. By comparison to …